Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Smith

Showing results (311-320 of 332) with videos related to

Pageof 34
Sort By:
Molecular Cancer Research : MCR|January 13, 2023
Malignant Progression of an Ancestral Bone Marrow Clone Harboring a CIC-NUTM2A Fusion in Isolated Myeloid SarcomaJennifer L Kamens, Jinjun Dang, Timothy I Shaw, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 15, 2002
Hazard identification by methods of animal-based toxicologyS M Barlow, J B Greig, J W Bridges, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Towards internationally acceptable standards for food additives and contaminants based on the use of risk analysisA Huggett, B J Petersen, R Walker, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 30, 2019
Bacterial community structure and response to nitrogen amendments in Lake Shenandoah (VA, USA)G Reynoso, M R Smith, C P Holmes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2023
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trialK N Chi, S Sandhu, M R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamideD E Rathkopf, M R Smith, C J Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2017
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweetA J Armstrong, E S Antonarakis, M-E Taplin, et al.
Nature Communications|February 13, 2023
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.
Nature Communications|March 9, 2023
Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.
Pageof 34

Showing results (311-320 of 332) with videos related to

Sort By:
Pageof 34
Molecular Cancer Research : MCR|January 13, 2023
Malignant Progression of an Ancestral Bone Marrow Clone Harboring a CIC-NUTM2A Fusion in Isolated Myeloid SarcomaJennifer L Kamens, Jinjun Dang, Timothy I Shaw, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 15, 2002
Hazard identification by methods of animal-based toxicologyS M Barlow, J B Greig, J W Bridges, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Towards internationally acceptable standards for food additives and contaminants based on the use of risk analysisA Huggett, B J Petersen, R Walker, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 30, 2019
Bacterial community structure and response to nitrogen amendments in Lake Shenandoah (VA, USA)G Reynoso, M R Smith, C P Holmes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2023
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trialK N Chi, S Sandhu, M R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamideD E Rathkopf, M R Smith, C J Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2017
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweetA J Armstrong, E S Antonarakis, M-E Taplin, et al.
Nature Communications|February 13, 2023
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.
Nature Communications|March 9, 2023
Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.
Pageof 34